Skip to main content
Clinical Trials/CTIS2023-503912-34-00
CTIS2023-503912-34-00
Recruiting
Phase 1

NAC for reversal of opioid-induced respiratory depression

eiden University Medical Center0 sites18 target enrollmentMarch 10, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
none, healthy subjects only
Sponsor
eiden University Medical Center
Enrollment
18
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 10, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age 18\-40 years, Body Mass Index 19\-30 kg/m2, Able to read and understand the subject information

Exclusion Criteria

  • A medical history of medical or psychiatric disease, any allergy to food or medication, weekly ethanol intake of more than 3 units/day or more than 21 units/week in women and 5 units/day and 35 units/week in men, pregnancy or lactation, women of childbearing potential (defined as all women who are not surgically sterile or postmenopausal for at least 1 year prior to informed consent) must have a negative urine pregnancy test prior to enrolment and must agree to use a medically acceptable means of contraception from screening through at least 1 month after the last dose of study drug, participation in an investigational drug trial in the 3 months before the current study, illicit drug use in the 30 days before the current study, a positive drug urine dipstick on the screening or study days

Outcomes

Primary Outcomes

Not specified

Similar Trials